Apolipoprotein E and Alzheimer's disease: A rapidly expanding field with medical and epidemiological consequences

Annals of the New York Academy of Sciences

Volumn 802, Issue , 1996, Pages 50-57

  Roses, Allen D ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E4;

AGING; ALZHEIMER DISEASE; CONFERENCE PAPER; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; GENETIC ASSOCIATION; GENETIC COUNSELING; GENOTYPE; HUMAN; MEDICAL ETHICS; ONSET AGE; RISK; SYMPOSIUM; TREATMENT PLANNING; UNITED STATES;

EID: 0030481305     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1996.tb32598.x     Document Type: Conference Paper

References (27)

1. STRITTMATTER, W. J., D. Y. HUANG, R. BHASIN, A. D. ROSES & D. GOLDGABER. 1993. Avid binding of beta A amyloid peptide to its own precursor. Exp. Neurol. 122: 327-334.
2. SAUNDERS, A. M., W. J. STRITTMATTER, D. SCHMECHEL, et al. 1993. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43: 1467-1472.
3. SAUNDERS, A. M., K. SCHMADER, J. C. BREITNER, et al. 1993. Apolipoprotein E epsilon 4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases. Lancet 342: 710-711.
4. UEKI, A., M. KAWANO, Y. NAMBA, M. KAWAKAMI & K. IKEDA. 1993. A high frequency of apolipoprotein E4 isoprotein in Japanese patients with late-onset nonfamilial Alzheimer's disease. Neurosci. Lett. 163: 166-168.
5. MURAMATSU, T., S. HIGUCHI, H. ARAI, et al. 1994. Apolipoprotein E epsilon 4 allele distribution in alcoholic dementia and in Alzheimer's disease in Japan. Ann. Neurol. 36: 797-799.
6. KAWAMATA, J., S. TANAKA, S. SHIMOHAMA, K. UEDA & J. KIMURA. 1994. Apolipoprotein E polymorphism in Japanese patients with Alzheimer's disease or vascular dementia. J. Neurol. Neurosurg. Psychiatry 57: 1414-1416.
7. OKUIZUMI, K., O. ONODERA, H. TANAKA, et al. 1994. ApoE-epsilon 4 and early-onset Alzheimer's. Nat. Genet. 7: 10-11.
8. MAYEUX, R., Y. STERN, R. OTTMAN, et al. 1994. The apolipoprotein epsilon 4 allele in patients with Alzheimer's disease. Ann. Neurol. 34: 752-754.
9. HENDRIE, H. C., K. S. HALL, S. HUI, et al. 1995. Apolipoprotein E genotypes and Alzheimer's disease in a community study of elderly African Americans. Ann. Neurol. 37: 118-120.
10. KUUSISTO, J., K. KOIVISTO, K. KERVINEN, et al. 1994. Association of apolipoprotein E phenotypes with late onset Alzheimer's disease: Population based study. Br. Med. J. 309: 636-638.
11. CORDER, E. H., A. M. SAUNDERS, W. J. STRITTMATTER, et al. 1993. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261: 921-923.
12. CORDER, E. H., A. M. SAUNDERS, N. J. RISCH, et al. 1994. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat. Genet. 7: 180-184.
13. ROSES, A. D. 1995. Apolipoprotein E genotyping in differential diagnosis, not prediction, of Alzheimer's disease (point of view). Ann. Neurol. 38: 6-14.
14. BIRD, T. D. 1995. Apolipoprotein E genotyping in the diagnosis of Alzheimer's disease: A cautionary view (Editorial). Ann. Neurol. 38: 2-3.
15. RELKIN, N. R., R. TANZI, J. BREITNER, et al. 1996. Apolipoprotein E genotyping in Alzheimer's disease. Lancet 347: 1091-1095.
16. MIRRA, S. S., A. HEYMAN, D. MCKEEL. et al. 1991. The consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41(4): 479-486.
17. KHACHATURIAN, Z. S. 1985. Diagnosis of Alzheimer's disease, Arch. Neurol. 42: 1097-1105.
18. SAUNDERS, A. M., C. HULETTE, K. A. WELSH, et al. 1996. Specificity, sensitivity and predictive value of apolipoprotein E genotyping in a consecutive autopsy series of sporadic Alzheimer disease. Lancet 348: 90-93.
19. SMITH, A. D., K. A. JOBST, C. JOHNSTON, C. JOACHIM & Z. NAGY. 1996. Apolipoprotein-E genotyping in diagnosis of Alzheimer's disease. Lancet 348: 483-484.
20. KAKULAS, B. A., S. D. WILTON, V. A. FABIAN & T. M. JONES. 1996. Apolipoprotein-E genotyping in the diagnosis of Alzheimer's disease in an autopsy confirmed series. Lancet 348: 483.
21. ROSES, A. D. 1996. The predictive value of APOE genotyping in the early diagnosis of dementia of the Alzheimer type: Data from three independent series. Proceedings of the Fifth International Conference on Alzheimer's Disease and Related Disorders 1996, Osaka, Japan, in press.
22. SLOOTER, A. J., M. M. B. BRETELER, A. OTT, C. VAN BROECKHOVEN & C. M. VAN DUIJN. 1996. APOE genotyping in differential diagnosis of Alzheimer's disease. Lancet 348: 334.
23. STEINBERG A. 1995. The foundations and the development of modern medical ethics. J. Assist. Reprod. Genet. 12(8): 473-476.
24. POIRIER, J., M.-C. DELISLE, R. QUIRION, et al. 1996. Apolipoprotein E4 as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease. Proc. Natl. Acad. Sci. USA, in press.
25. WILCOCK, G.K. 1995. Apolipoprotein E genotype and response to Tacrin in Alzheimer's disease. In: Apolipoprotein E and Alzheimer's Disease. A. Roses, K. Weisgraber & Y. Christen, Eds. Springer-Verlag. Berlin. In press.
26. AMOUYEL, P., E. NEUMAN, L. DILLEMAN, et al. 1995. Characterization of the apolipoprotein E genotypes in clinical trials of Alzheimer's disease: The S12024 (memory enhancer) European multicentre project. In Apolipoprotein E and Alzheimer's Disease. A. Roses K. Weisgraber & Y. Christen, Eds. Springer-Verlag. Berlin. In press.
27. ALTSTIEL, L., R. MOHS, D. MARIN, et al. 1995. APOE genotype and clinical outcome in Alzheimer's disease. In A. Roses, K. Weisgraber & Y. Christen, Eds. Apolipoprotein E and Alzheimer's disease. Springer-Verlag. Berlin. In press.